LEO Pharma appoints Leanne Walsh as general manager and vice president for UK and Ireland

Betsy Goodfellow | June 19, 2023 | Appointment | |  LEO Pharma, appointment, general manager, vice president 

Medical dermatology company LEO Pharma has announced that it has appointed Leanne Walsh as its new general manager and vice president for the UK and Ireland, having previously worked as general manager for Northern Europe at Aimmune Therapeutics.

Walsh has over 20 years of experience in the pharmaceutical industry at a global, European and affiliate level. In previous roles she has worked on and led various launches of novel therapies in competitive spaces, for complex, niche and specialist markets.

Commenting on her new role, Walsh stated: “I am excited to join the LEO Pharma UK and Ireland team. I firmly believe that LEO Pharma has the opportunity to be the preferred dermatology care partner and can exceed the expectations of both our partners and patients through transformation, dedication and a true partnership approach with all our stakeholders. […] My key priorities in this role are to drive proactive innovation and nurture an inclusive work environment where all internal and external stakeholders are inspired to take action to improve the lives of those living with skin conditions. The medical dermatology industry is evolving rapidly, which presents real opportunities for LEO Pharma, and I look forward to the exciting journey ahead.”

Advertisement

Walsh began her new role on 12 June 2023.

Related Content

Boehringer Ingelheim and LEO Pharma partner to develop treatment for generalised pustular psoriasis

Boehringer Ingelheim and LEO Pharma have partnered to commercialise and further develop Spevigo (spesolimab), a …

cream-4713579_1920

LEO Pharma initiates phase 2a trial of delgocitinib cream for rare skin condition

LEO Pharma has initiated a phase 2a trial investigating delgocitinib cream in adults with mild-to-severe …

MHRA Grants Marketing Authorisation for LEO Pharma’s Anzupgo® ▼(delgocitinib) cream in Great Britain

The Medicines and Healthcare Products Regulatory Agency (MHRA) has granted marketing authorisation in Great Britain …

The Gateway to Local Adoption Series

Latest content